Results 121 to 130 of about 7,464 (222)

Tracing the evolution of polypharmacy and contraindicated drug‒drug interactions in people living with HIV in Belgium. [PDF]

Front Pharmacol
Lopez Delhoulle V, Destordeur LC, Maes N, Fombellida K, El Moussaoui M, Darcis G.   +5 more
europepmc   +1 more source

To Switch or not to Switch: are there any Antiretroviral Strategies to Attenuate Weight Gain in People with HIV? [PDF]

Curr HIV/AIDS Rep
Debroy P, Lake JE.
europepmc   +1 more source

Concurrent cerebral toxoplasmosis and cytomegalovirus retinitis in a patient with human immunodeficiency virus [PDF]

, 2019
Giuliari, G. Paolo, Kuruppu, Dulanji K., Mackay, Devin D.   +2 more
core   +1 more source

Population Pharmacokinetics of Cobicistat and its Effect on the Pharmacokinetics of the Anticancer Drug Olaparib. [PDF]

Clin Pharmacokinet
Overbeek JK, van Erp NP, Burger DM, den Broeder AA, Koolen SLW, Huitema ADR, Ter Heine R.   +6 more
europepmc   +1 more source

Care of HIV Patients in Long-Term Care Facilities: A Growing Concern and a Call to Action. [PDF]

Arch Clin Med Case Rep
Liu M, King WD, Butler D, Liu MH.
europepmc   +1 more source

Sustained HIV Viral Suppression 18 Months After the Last Dose of Long-acting Cabotegravir/Rilpivirine: A Case Report. [PDF]

Open Forum Infect Dis
Sunagawa SW, Bares SH, Scarsi KK, Podany A, Mykris T, Weinhold J, O'Neill J, Kubat M, Cramer D, Davis JM, Havens JP.   +10 more
europepmc   +1 more source

Toxoplasmic Encephalitis Presenting as a Stroke Mimic in an AIDS Patient: A Case Report. [PDF]

Cureus
Rincon-Ponte AM, Santibañez M, Woods R.
europepmc   +1 more source

Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing [PDF]

, 2016
Chaponda, Mas, Khoo, Saye, Lewis, Joseph M, Railton, Eimear, Riordan, Andrew   +4 more
core   +1 more source

Two cases of possible transmitted HIV drug resistance to all currently available integrase inhibitors, the Netherlands, 2025. [PDF]

Euro Surveill
van Kampen J, Voermans J, Soochit W, Mesplède T, van de Laar T, van der Reijden W, Burger D, Shalev N, van Sighem A, Bezemer D, Jurriaans S, van der Vaart T, de Jong H, van der Valk M.   +13 more
europepmc   +1 more source

Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1 : a Phase IIa randomised controlled study [PDF]

, 2019
Barrett, P Noel, Cole, Basiel, Ehrlich, Hartmut J, Gineste, Paul, Kint, Sam, Rutsaert, Sofie, Scherrer, Didier, Steens, Jean-Marc, Tazi, Jamal, Vandekerckhove, Linos   +9 more
core